Recital 2, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

Novozymes is a global biotechnology company headquartered in Bagsvaerd,

Denmark. Novozymes provides biological solutions for industrial and consumer use. It is a manufacturer of industrial enzymes and microorganisms including probiotics and biologicals for plant health. It is Nasdaq listed with Novo Holdings A/S (the “Novo Holdings”) as the majority and controlling shareholder with 29.7% of the shares and 74.4% of the voting rights.4